Xylem Inc. (XYL)
Xylem Statistics
Share Statistics
Xylem has 243.05M shares outstanding. The number of shares has increased by 0.25% in one year.
Shares Outstanding | 243.05M |
Shares Change (YoY) | 0.25% |
Shares Change (QoQ) | 0.04% |
Owned by Institutions (%) | 90.59% |
Shares Floating | 241.5M |
Failed to Deliver (FTD) Shares | 44 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 3.36M, so 1.38% of the outstanding shares have been sold short.
Short Interest | 3.36M |
Short % of Shares Out | 1.38% |
Short % of Float | 1.39% |
Short Ratio (days to cover) | 2.7 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 26.04. Xylem's PEG ratio is undefined.
PE Ratio | undefined |
Forward PE | 26.04 |
PS Ratio | 3.29 |
Forward PS | 2.9 |
PB Ratio | 2.64 |
P/FCF Ratio | undefined |
PEG Ratio | undefined |
Enterprise Valuation
Xylem Inc. has an Enterprise Value (EV) of 26.46B.
EV / Earnings | 29.73 |
EV / Sales | 3.09 |
EV / EBITDA | 16.2 |
EV / EBIT | 24.66 |
EV / FCF | 28.09 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of undefined.
Current Ratio | 1.76 |
Quick Ratio | 1.33 |
Debt / Equity | undefined |
Total Debt / Capitalization | - |
Cash Flow / Debt | null |
Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is null% and return on capital (ROIC) is 6.81%.
Return on Equity (ROE) | null% |
Return on Assets (ROA) | null% |
Return on Capital (ROIC) | 6.81% |
Revenue Per Employee | $372,260.87 |
Profits Per Employee | $38,695.65 |
Employee Count | 23,000 |
Asset Turnover | 0.52 |
Inventory Turnover | 5.37 |
Taxes
Income Tax | 197M |
Effective Tax Rate | 0.18 |
Stock Price Statistics
The stock price has increased by -6.59% in the last 52 weeks. The beta is 1.08, so Xylem's price volatility has been higher than the market average.
Beta | 1.08 |
52-Week Price Change | -6.59% |
50-Day Moving Average | 125.48 |
200-Day Moving Average | 128.65 |
Relative Strength Index (RSI) | 40.47 |
Average Volume (20 Days) | 1.49M |
Income Statement
In the last 12 months, Xylem had revenue of 8.56B and earned 890M in profits. Earnings per share was 3.67.
Revenue | 8.56B |
Gross Profit | 3.21B |
Operating Income | 1.07B |
Net Income | 890M |
EBITDA | 1.63B |
EBIT | 1.07B |
Earnings Per Share (EPS) | 3.67 |
Balance Sheet
The company has 1.12B in cash and 2.02B in debt, giving a net cash position of -895M.
Cash & Cash Equivalents | 1.12B |
Total Debt | 2.02B |
Net Cash | -895M |
Retained Earnings | 3.14B |
Total Assets | 16.5B |
Working Capital | 1.77B |
Cash Flow
In the last 12 months, operating cash flow was 1.26B and capital expenditures -321M, giving a free cash flow of 942M.
Operating Cash Flow | 1.26B |
Capital Expenditures | -321M |
Free Cash Flow | 942M |
FCF Per Share | 3.88 |
Margins
Gross margin is 37.51%, with operating and profit margins of 12.53% and 10.39%.
Gross Margin | 37.51% |
Operating Margin | 12.53% |
Pretax Margin | 12.7% |
Profit Margin | 10.39% |
EBITDA Margin | 19.07% |
EBIT Margin | 12.53% |
FCF Margin | 11% |
Dividends & Yields
XYL pays an annual dividend of $1.84, which amounts to a dividend yield of 1.13%.
Dividend Per Share | $1.84 |
Dividend Yield | 1.13% |
Dividend Growth (YoY) | 11.11% |
Payout Ratio | 50.41% |
Earnings Yield | 3.07% |
FCF Yield | 3.24% |
Analyst Forecast
The average price target for XYL is $150, which is 25.3% higher than the current price. The consensus rating is "Buy".
Price Target | $150 |
Price Target Difference | 25.3% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Scores
Altman Z-Score | 4.3 |
Piotroski F-Score | 7 |